Navigation Links
Versailles Group Announces Accentus, Inc. Acquired by High Road Capital Partners
Date:4/21/2009

BOSTON, April 21 /PRNewswire/ -- Versailles Group, Ltd. (http://www.versaillesgroup.com) announced today Accentus, Inc. (http://www.accentus.ca) has been acquired by High Road Capital Partners (http://www.highroadcap.com) of New York.

Based in Ottawa, Ontario, Accentus is the largest provider in the Canadian outsourced medical transcription industry. Accentus provides medical transcription and editing services to over half of all hospitals, clinics, and independent physician groups throughout Canada.

Versailles Group, a 22-year-old Boston-based investment bank that specializes in international mergers, acquisitions, and divestitures, advised Accentus' shareholders on the transaction. Versailles Group has worked with companies in the U.S., Europe, Canada, and Latin America.

"With more than two decades of experience, Versailles Group is the expert in finding the right buyer for its domestic and international clients," said Don Grava, founder and president. "We are pleased that we successfully did so for Accentus."

"Accentus has been a leader in its industry for nearly a decade," he said. "When owners Steve and Rod Rogers retained Versailles Group for their divestiture, they knew that the combination of Versailles Group's skill and Accentus' performance would net them a superior valuation and a successful transaction. The clients' expectations were surpassed."

Versailles Group had previously sold two other businesses for the Rogers Family, Taima Corporation to Convergys Corporation and The PSC Communications Group Inc. to MacDonald Dettwiler & Associates.

Stephen Rogers, CEO of Accentus, and a significant investor in the divestiture along with brother and president Roderick Rogers, said, "Accentus has played a key role in developing the market for outsourced medical transcription and editing services in Canada." Rogers said that he and his brother "saw tremendous opportunity to accelerate Accentus' growth in partnership with High Road while continuing to provide exceptional service to our customers."

Senior debt financing for the transaction was provided by Bank of Montreal. Subordinated debt financing was provided by Bank of Montreal Capital Corporation, which invested along with High Road and Accentus management.

Transaction consideration was not disclosed.

Versailles Group, Ltd.

Versailles Group, Ltd. is a Boston-based investment bank that specializes in international mergers, acquisitions, and divestitures. Versailles Group's skill, flexibility, and experience have enabled it to successfully close transactions in any economic environment. More information on Versailles Group can be found on its website, http://www.versaillesgroup.com.

    For more information:

    Donald Grava (617) 449-3325
    dgrava@versaillesgroup.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Versailles Group, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
5. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
6. AMERIGROUP to Acquire Memphis Health Plan
7. Securians Minnesota Life Continues to Climb Group Life Rankings
8. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
9. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
10. Group B Strep: A Threat to Newborns That Doesnt Have to Be
11. Cynosure to Present at the Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Leading ... that address medical conditions resulting from a breakdown ... has appointed Greg Doyle as chief ... Leading BioSciences, executive management team and board of ... chief financial officer. He will provide continued leadership ...
(Date:6/23/2016)... June 23, 2016 Research and ... in Europe 2016 Edition: The New Global Agenda " ... OTC Distribution in Europe - ... explores and tracks change. It identifies the driving factors coming ... the consumer healthcare industry now and in the future. It ...
(Date:6/23/2016)... June 23, 2016 The ... the development of combination therapies trend is expected ... treatment of CLL were available only in the ... are chlorambucil in combination with prednisone, and a ... a growing trend of developing combination therapies to ...
Breaking Medicine Technology: